Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03589469
Title Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ADC Therapeutics S.A.

B-cell lymphoma

diffuse large B-cell lymphoma


Loncastuximab tesirine-lpyl

Age Groups: senior | adult
Covered Countries USA | ITA

No variant requirements are available.